DT & IT Pharma Townhall 06/24 | Bayer
2024-06-20
Thank you for attending today's DT & IT Pharma Townhall! In today's meeting, we delved deeper into the successful launch of the Pharma Control Tower (go/PHCT), which serves as a central entry point for all your needs related to financial, operational stability, and governance for your applications, portfolios, and functions. Additionally, we shared some updates on the rollout of MyGenAssist at Pharma, highlighting our crucial role as key ambassadors. This past year has underscored the accelerated pace of innovation, with GenAI standing out as a prime example of the agility needed to proactively evolve our skill sets. Furthermore, we collectively reviewed our key priorities for 2024 and provided updates on our DSO learning journey. In summary: ///// PH Control Tower ///// Business priorities per department ///// MyGenAssist roll-out PH ///// DSO Champions update Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc
Dear CID expert, you have met all Team members today in valuable 90 min. to exchange on DSO & other topics of expertise with the chance to clarify open questions. We are ONE Team and have the same spirit like our peers in the Bayer 04 Leverkusen soccer team. Stay tuned & let's connect! ___ Image created by Stefankai with Midjourney AI and Canva Bayer POAP Term&Conditions: https://bayer.com/poap More info on business use of POAPS at https://go/poap Explore Bayer POAP Collection at https://collections.poap.xyz/bayer
First Open MIC DSO Exchange 2024 | Bayer
2024-02-05
Thank you for joining our first DSO Open Mic session in 2024!! These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded.
Last Pharma IT Townhall 23 | Bayer
2023-12-15
Dear Team, A huge thank you to everyone who joined our recent Global DT&IT Pharma Townhall. Your participation not only made it a success, it also added to the beauty of this time of the year when the snowflakes fall and the air transmits the smell of muled wine and fresh bakery. Reflecting on our team's achievements and exploring Dynamic Shared Ownership (DSO) was insightful, thanks to your active engagement. The shared pictures highlighted our milestones beautifully. Your contributions in discussions and ideas truly enriched the event. Your dedication and support are immensely valued. Let's continue fostering collaboration and empowerment in our work. Thanks again for being a part of this success! Best regards, Patrick Text's draft modified by Open AI's ChatGPT Art inspired by Open AI's Dall-E
Head of Business Disruption, Bayer Pharmaceuticals. I love Stranger Things, Science4Berlin, STEM4Health, Hackathons, Biotech, Digital Health, Startups, Web3, Networking For Health, Science, Technology, Pharma, Medicine, Exobiology, Space, Science Fiction, Germany, Cuba. Working on OhrSum. https://www.linkedin.com/in/yeysus/ https://twitter.com/yeysus yeysus.eth/.tez/.near POAPs collections: Bayer: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/1 Bayer Haemophilia: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/24 Bayer Women's Health: https://welook.io/u/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/42 Bayer Hellas / Greece: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/27 Bayer Uruguay: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/38 Bayer Berlin: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/29 Bayer IT: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/30 Bayer R&D: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/31 Bayer Medical Affairs: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/33 Bayer Communities: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/32 Art by Stable Diffusion after prompting with ChatGPT Plus. Thanks for depicting me much younger than I am.